Instituto do Câncer do Estado de São Paulo Octavio Frias de Oliveira - ICESP

São Paulo, São Paulo 01246-000

0 studies enrolling now · 3 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Non Squamous Lung Cancer, Non-small Cell Lung Cancer

Studies at this site

• A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung — Completed
• An Investigational Drug, PF-02341066, Is Being Studied In Patients With Advanced Non-Small Cell Lung Cancer With A Specific Gene Profile Involving The Anaplastic Lymphoma Kinase (ALK) Gene — Completed
• A Randomized Trial Of PF-00299804 Taken Orally Versus Erlotinib Taken Orally For Treatment Of Advanced Non-Small Cell Lung Cancer That Has Progressed After One Or Two Prior Chemotherapy Regimen — Completed